The Department of Justice announced that six Dallas, Texas-area pharmacy owners and marketers were charged for their role in a $14 million healthcare fraud scheme involving illegal kickbacks and...
Premier Inc recently found that drug shortages to treat cardiovascular conditions have increased due to the COVID-19 pandemic, according to a press release.
For more coronavirus updates, visit...
Three pharmaceutical companies recently formed a partnership to support the discovery and development of next-generation cancer immunotherapies.
For more coronavirus updates, visit...
Johnson & Johnson (J&J) recently announced a collaboration between Janssen Pharmaceuticals and Emergent BioSolutions to support the manufacturing of its lead investigational COVID-19 vaccine...
Pfizer and BioNTech recently disclosed additional details on their COVID-19 vaccine development plans through BioNTech’s and mRNA vaccine program.
For more coronavirus updates, visit...
Novartis recently announced its commitment to donate up to 130 million doses of generic hydroxychloroquine, a potential COVID-19 treatment.
For more coronavirus updates, visit our resource...
The American Society of Health-System Pharmacists (ASHP) recently called on the Trump Administration to address shortages of supportive ventilator drugs as COVID-19 continues to infect more...
FDA recently announced it has requested that manufacturers withdraw all prescription and over-the-counter (OTC) ranitidine drugs from the market immediately.
Last year, FDA became aware of independent...
When matched for all characteristics, two biosimilars showed significant cost savings for large US employers, according to researchers from the Bloomberg School of Public Health at Johns Hopkins...
The FDA finally approved Zeposia (ozanimod), a multiple sclerosis (MS) drug developed by Celgene, according to a recent announcement from the Bristol-Myers Squibb Company.
Bristol-Myers acquired...
CVS Caremark, the pharmacy benefit manager business of CVS Health, recently announced that it is working with clients to implement new measures to protect and strengthen the COVID-19 supply chain,...
Hospitalized adult patients with confirmed COVID-19, experienced no benefits in lopinavir- ritonavir treatment compared to standard care, according to a recent clinical trial, LOTUS China...
Pharmaceutical Care Management Association (PCMA) president and CEO JC Scott issued a letter to the Trump Administration’s COVID-19 Task Force affirming pharmacy benefit managers’ (PBMs)...
As the FDA closely monitors the coronavirus supply chain, it has uncovered a drug shortage related to a site affected by the coronavirus, or COVID-19, according to a recent statement from Stephen M....
The Institute for Clinical and Economic Review’s (ICER) final evidence report assessing the clinical effectiveness and economic value of three acute treatments for migraines had more favorable...
GW Pharmaceuticals announced last week that its cannabinoid (CBD) prescription medicines brought in total revenue of $109.1 million for the fourth quarter of 2019, and $311.3 million for the full...
A novel strain of the coronavirus has the world scrambling to avoid a global pandemic. In December 2019, the new virus emerged in Wuhan, China.
Similar to the severe acute respiratory syndrome (SARS)...
The FDA recently announced a collaboration with Radiological Health and Center for Drug Evaluation and Research to develop a web-based resource intended to support the current science in...
The Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) on Monday issued a set of four joint goals to support a competitive US marketplace for approved biological products,...
Eli Lilly will open its first “state-of-the-art” manufacturing facility in North Carolina for the manufacturing of injectable products and delivery devices, the Indianapolis firm said...
